Doxycyclin
Sponsors
Tanta University, Hedi Gharsallah, Shaheed Zulfiqar Ali Bhutto Medical University, Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit, Bulovka Hospital
Conditions
BlepharitisBreast CancerCovid19Diabetes Mellitus, Type 2Doxycycline Adverse ReactionDyspepsiaGonorrheaInfectious Disease
Phase 1
Phase 2
Combination Therapy Between Doxycycline, Pentoxifylline, and Nitazoxanide in Sexually Active Men
Not yet recruitingNCT05897034
Start: 2023-06-20End: 2028-06-20Target: 100Updated: 2023-06-12
Rickettsia Clearance Study
RecruitingNCT05972772
Start: 2024-11-01End: 2026-08-31Target: 72Updated: 2024-12-27
NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline
RecruitingNCT06452394
Start: 2025-07-16End: 2028-12-31Target: 50Updated: 2025-12-30
Phase 3
Phase 4
Cefixime Plus Doxycycline Compared to Ceftriaxone Plus Azithromycin for Treatment of Gonorrhoea
CompletedNCT06090565
Start: 2021-04-01End: 2022-12-22Updated: 2023-10-23
Weekly Doxycycline DOT for STI Prevention Among Cisgender Women Taking HIV PrEP in Kisumu, Kenya
CompletedNCT06582966
Start: 2024-08-13End: 2024-12-31Updated: 2025-02-06
Unknown Phase
Comparison Of Doxycycline And Common Salt For Treatment Of Umbilical Granuloma: A Randomised Control Trial
CompletedNCT05545462
Start: 2020-10-01End: 2021-09-30Updated: 2022-09-19
Comparison Between Continuous and Pulsed Oral Doxycycline Treatment Protocols for Refractory Meibomian Gland Dysfunction
CompletedNCT06520007
Start: 2023-03-01End: 2024-05-01Updated: 2024-07-25